Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by blogon May 13, 2007 3:55pm
278 Views
Post# 12773391

Looking for ghosts

Looking for ghostsI have listened to the recent transcripts and presentations; in my opinion after a major operation with someone else’s kidney it’s fully understandable that the host is going to have issues. So why blame it on the unknown, for example, why blame a drug or combination of drugs. This industry is just like all others, that being self serving. Some of the take home messages of the presentations are its unknown if the drug cocktail or the calcinurin inhibitor is making a difference on renal toxicity. Also its undecided which drugs are the culprit in regards to toxic side affects; it all could be the result of the new organ (natural occurrence from transplantation). This said, it’s well known and documented that calcenurin inhibitors save lives, this is one of the few knows.
Bullboard Posts